LARRY C II HEATON

CIK 1213207 · CEO · last filed 2026-05-08

LARRY C II HEATON is a CEO who has filed 10 SEC Form 4 insider transactions across 1 company since 2021. Across all open-market trades the lifetime net is +$74.6K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

10

Lifetime Open-Market Net

$74.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Zomedica Corp. (ZOM) Delisted CEO 500,000 $0.10 $48.6K $74.6K 7 2024-11-12

Recent Filings

10 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-05-08 Buy (P) +250,000 $27.5K
2025-06-16 Grant (A) $0
2025-03-18 Buy (P) +500,000 $29.7K
2024-11-12 Zomedica Corp. (ZOM) Delisted Buy (P) +100,000 $12.2K EDGAR
2024-09-05 Zomedica Corp. (ZOM) Delisted Buy (P) +100,000 $12.5K EDGAR
2024-05-13 Zomedica Corp. (ZOM) Delisted Buy (P) +100,000 $14.2K EDGAR
2023-11-17 Zomedica Corp. (ZOM) Delisted Buy (P) +100,000 $16.6K EDGAR
2023-05-26 Zomedica Corp. (ZOM) Delisted Buy (P) +100,000 $19.1K EDGAR
2022-10-06 Zomedica Corp. (ZOM) Delisted Grant (A) $0 EDGAR
2021-10-05 Zomedica Corp. (ZOM) Delisted Grant (A) $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.